LKT Labs

Biochemicals for Life Science Research

Reversine

Reversine

Product ID R1885
Cas No. 656820-32-5
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $102.00 Please Inquire
5 mg $216.00 Please Inquire
10 mg $380.00 Please Inquire
25 mg $810.00 Please Inquire
Bulk Quote

Quicklinks

Description

Reversine is a purine analog that reverses or induces differentiation. Reversine displays anticancer chemotherapeutic and anti-metastatic activities; it transforms preadipocytes into mesenchymal stem cells, induces autophagy in thyroid cancer cells, and downregulates expression of miR-133a miRNA. This compound induces apoptosis and cell death in breast cancer cells. In animal models of cancer, reversine inhibits focal adhesion disassembly, decreases cell motility and invasion, and prevents tumor metastasis.

Product Info

Cas No.

656820-32-5
Purity

≥98%
Formula

C21H27N7O
Formula Wt.

393.50
IUPAC Name

N6-Cyclohexyl-N2-[4-(4-morpholinyl)phenyl]-3H-purine-2,6-diamine
Solubility

DMSO: 7mg/mL water: insoluble

Shipping and Storage

Store Temp

4°C
Ship Temp

Ambient

Downloads

MSDS

R1885 MSDS PDF
Info Sheet

R1885 Info Sheet PDF

References

Kuo CH, Lu YC, Tseng YS, et al. Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells. Breast Cancer. 2014 May;21(3):358-69. PMID: 22926505.

Park JG, Lee DH, Moon YS, et al. Reversine increases the plasticity of lineage-committed preadipocytes to osteogenesis by inhibiting adipogenesis through induction of TGF-β pathway in vitro. Biochem Biophys Res Commun. 2014 Mar 28;446(1):30-6. PMID: 24548409.

Kim M, Yi SA, Lee H, et al. Reversine induces multipotency of lineage-committed cells through epigenetic silencing of miR-133a. Biochem Biophys Res Commun. 2014 Feb 28;445(1):255-62. PMID: 24513286.

Bijian K, Lougheed C, Su J, et al. Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine. Br J Cancer. 2013 Nov 26;109(11):2810-8. PMID: 24169345.

Lu CH, Liu YW, Hua SC, et al. Autophagy induction of reversine on human follicular thyroid cancer cells. Biomed Pharmacother. 2012 Dec;66(8):642-7. PMID: 23089471.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • F5868

    Formoterol Fumarate Dihydrate

    β2-adrenergic agonist.

    ≥98%
  • X4402

    XL-147

    Dual inhibitor of PI3K and mTOR.

    ≥98%
  • E6880

    Erucin

    Isothiocyanate found in cruciferous vegetables,...

    ≥98%
  • A0960

    Adrenocorticotropic Hormone (1-39), human

    Endogenous peptide hormone, involved in stress ...

    ≥95%
  • A4496

    Alyssin

    Naturally sourced ITC, sulfonyl analog of sulfo...

    ≥97%
  • H1695

    S-Hexylglutathione

    Glutathione-S-transferase inhibitor.

    ≥98%
  • T3468

    Tirapazamine

    Topoisomerase II inhibitor, RPA modulator.

    ≥98%
  • P327212

    Pifithrin-α-cyclic Hydrobromide

    p53 inhibitor

    ≥98%
  • M576486

    Mometasone Furoate

    Synthetic glucocorticoid

    ≥98%
  • A4805

    Amastatin Hydrochloride Hydrate

    Aminopeptidase inhibitor.

    ≥98%
  • D0005

    Dabrafenib Mesylate

    B-Raf and c-Raf inhibitor.

    ≥98%
  • T7034

    Trimethoprim

    Dihydrofolate reductase inhibitor.

    ≥98%
  • G7862

    GTPL-5846

    GPR84 agonist.

    ≥98%
  • S0501

    SB-939

    HDAC inhibitor.

    ≥98%
  • A5135

    Aminophylline Dihydrate

    Xanthine derivative; adenosine antagonist, PDE ...

    ≥98%
  • C1176

    CCT-128930

    Pyrrolopyrimidine; Akt inhibitor.

    ≥98%
  • A5280

    Angiotensin II (3-8), human

    Endogenous peptide fragment, involved in vasoco...

    ≥95%
  • D6958

    Droloxifene Citrate

    Tamoxifen analog; SERM.

    ≥98%
  • I7359

    1-Isothiocyanato-8-(methylsulfenyl)-octane

    ITC, erucin analog.

    ≥98%
  • T3203

    Tianeptine Sodium Hydrate

    μOR and δOR agonist, D2/D3 DA potentiator.

    ≥98%